The cell analysis market is expected to reach US$ 43.67 Billion by 2032.
The cell analysis market is expected to grow at a CAGR of 9.61% during the period from 2023 to 2032.
The cell analysis market was estimated to be US$ 17.45 Billion in 2022.
North America dominates the cell analysis market and is anticipated to continue its dominance in the forecasted period.
Pharmaceutical and biotechnology companies dominate the end-user segment in the market. This dominance is attributed to the rising investments of these companies in the research and development of drugs to treat many chronic diseases.
Thermo Fisher Scientific, Danaher, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, General Electric, Olympus Corporation, Bio-Rad Laboratories, Miltenyi Biotec, BioStatus Limited, Fluidigm Corporation, NanoCellect Biomedical, Cell Biolabs, Creative Bioarray, Meiji Techno, Promega Corporation, PerkinElmer, Tecan Trading AG, CELLINK, QIAGEN, Corning Incorporated among others, are the major players in the cell analysis market.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved